<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on a patient with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), classified as refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blasts-2, and histiocytoid <z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:mp ids='MP_0001212'>skin lesions</z:mp> disappeared after initiation of <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and <z:chebi fb="1" ids="50845">doxycycline</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Remarkably, two months later a complete remission of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> occurred </plain></SENT>
<SENT sid="3" pm="."><plain>Fourteen months later both the <z:mp ids='MP_0001212'>skin lesions</z:mp> and the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> relapsed </plain></SENT>
<SENT sid="4" pm="."><plain>Antileukaemic activity following reversion of the impaired cellular immunity due to an increased number of natural killer cells in his bone marrow may be responsible for this rare event </plain></SENT>
<SENT sid="5" pm="."><plain>Inhibition of T-cell mediated <z:e sem="disease" ids="C0854467" disease_type="Disease or Syndrome" abbrv="">myelosuppression</z:e> by <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> or a proapoptotic effect of <z:chebi fb="1" ids="50845">doxycycline</z:chebi> may have attributed as well </plain></SENT>
</text></document>